Table 3.
Genetic variants which showed interaction with LTPA in DPS: ABCC8 rs3758947; ADRA2B 12Glu9; PPARG rs17036314, rs1801282; SLC2A2 rs5393, rs5394, rs5404; Loci of genetic variants which showed no interaction with LTPA in DPS: ABCC8 (3), ADRB2 (1), ADRB3 (1), GHRL (6), IGF1R (1), IL6 (1), KCNJ11 (1), LEPR (3), LIPC (1), TNF (1), PPARG (1), SLC2A2 (1) |
Genetic variants which showed interaction with PA in cohort studies: HNF1B rs4430796a, IRS1 rs1522813b, T2D‐GRS (65)c, IR‐GRS (SNPs of four genes)c, FI‐GRS (SNPs of nine genes)c Loci of genetic variants which showed no interaction with PA in cohort studies: PPARD (9)d, PPARGC (9)d, T2D‐GRS (14)d, T2D‐GRS (36)d, T2D‐GRS (SNPs of 49 genes)e, FG‐GRS (36)c, BC‐GRS (SNPs of nine genes)c, 65 T2D SNPsc, 16 T2D SNPsa |
Numbers in brackets indicate the numbers of investigated SNPs.
Malmö Preventive Project.
Nurses' Health Study/Health Professionals Follow‐Up Study.
Atherosclerosis Risk in Communities study.
Shanghai Diabetes GWAS Study.
InterAct.
Abbreviations: BC, beta cells; DPS, Diabetes Prevention Study; FG, fasting glucose; FI, fasting insulin; GRS, gene risk score; IR, insulin resistance; LTPA, leisure‐time physical activity; PA, physical activity; SDGS, Shanghai Diabetes GWAS Study; T2D, type 2 diabetes mellitus.